Integra LifeSciences | IART - Interest Expense On Debt


Integra LifeSciences reported $22.96M in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 64M 14M Jun/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Boston Scientific USD 100M 4M Sep/2026
CONMED USD 11.14M 3.25M Sep/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dexcom USD 3.1M 100K Sep/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
HeartBeam USD 744K 2K Dec/2021
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.96M 33K Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 186M 10M Jun/2026
Merit Medical Systems USD 7.33M 4.78M Sep/2026
Orthofix International 4.68M 731K Sep/2025
Smith & Nephew USD 69M 1000K Dec/2025
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026